BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Bispecific and bifunctional fusion proteins for cancer therapy
DTSTART:20170410T170000
DTEND:20170410T180000
DTSTAMP:20260921T104915Z
UID:5f6f5119f98f19b201dc237ea8633708e8d28996eaf05ac2c311c1c1
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Roland Kontermann\, University of Stuttgart\nProf. Konte
 rmann's research interests focus on the development of recombinant antibod
 ies (small bispecific and bifunctional antibody molecules\, humanized anti
 bodies) with improved biological and pharmacokinetic properties and target
 ed nanoparticulate carrier systems for cancer therapy. \n 
LOCATION:BCH 4310 https://plan.epfl.ch/?room==BCH%204310
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR